» Articles » PMID: 8806092

NCI-Navy Medical Oncology Branch Cell Line Data Base

Overview
Date 1996 Jan 1
PMID 8806092
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

The cell line data base described in this paper includes both clinical information about the patients from whom the cell lines were derived and information about the in vitro analyses performed of the cell lines. The cell line data base has evolved as a part of a systematic effort by a research group at the NCI since 1976 to generate human cell lines as biological tools to study cancer and other diseases. The cell lines were generated from clinical specimens obtained as part of a series of Institutional Review Board-approved clinical protocols. The preponderance of the data is on lung cancer cell lines, though a broad range of other cancers are represented. A bank of over 300 human cell lines including cancer cell and in some instances autologous B-lymphoblastoid cells from the NCI-VA and NCI-Navy Medical Oncology Branch are reposited at the American Type Culture Collection. The cell lines are available for the research community. The entire data base is available on the American Type Culture Collection Web Site (WWW:http:@www.atcc.org/).

Citing Articles

Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?.

Healy F, Turner A, Marensi V, MacEwan D Front Pharmacol. 2024; 15:1441938.

PMID: 39372214 PMC: 11450236. DOI: 10.3389/fphar.2024.1441938.


Combined blockade of GPX4 and activated EGFR/HER3 bypass pathways inhibits the development of ALK-inhibitor-induced tolerant persister cells in ALK-fusion-positive lung cancer.

Furugaki K, Fujimura T, Sakaguchi N, Watanabe Y, Uchibori K, Miyauchi E Mol Oncol. 2024; 19(2):519-539.

PMID: 39369284 PMC: 11793004. DOI: 10.1002/1878-0261.13746.


PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer.

Khan S, Cao L, Wiegand J, Zhang P, Zajac-Kaye M, Kaye F bioRxiv. 2024; .

PMID: 38464204 PMC: 10925307. DOI: 10.1101/2024.02.27.582353.


Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.

Pal Choudhuri S, Girard L, Lim J, Wise J, Freitas B, Yang D Cancer Discov. 2024; 14(5):804-827.

PMID: 38386926 PMC: 11061613. DOI: 10.1158/2159-8290.CD-23-0656.


Lack of racial and ethnic diversity in lung cancer cell lines contributes to lung cancer health disparities.

Leon C, Manley Jr E, Neely A, Castillo J, Ramos Correa M, Velarde D Front Oncol. 2023; 13():1187585.

PMID: 38023251 PMC: 10651223. DOI: 10.3389/fonc.2023.1187585.